Home/Filings/4/0001209191-17-025755
4//SEC Filing

Flexion Therapeutics Inc 4

Accession 0001209191-17-025755

CIK 0001419600operating

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 5:18 PM ET

Size

5.5 KB

Accession

0001209191-17-025755

Insider Transaction Report

Form 4
Period: 2017-04-03
Deniz Yamo
Chief Medical Officer
Transactions
  • Award

    Stock option (right to buy)

    2017-04-03+150,000150,000 total
    Exercise: $27.43Exp: 2027-04-02Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on April 3, 2018; thereafter one-forty-eighth (1/48th) of the shares subject to the option shall vest each month following April 3, 2018, so that all of the shares subject to the option shall be vested after April 3, 2021.

Issuer

Flexion Therapeutics Inc

CIK 0001419600

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001419600

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 5:18 PM ET
Size
5.5 KB